These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23275831)

  • 61. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
    Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
    Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors.
    Boland S; Bourin A; Alen J; Geraets J; Schroeders P; Castermans K; Kindt N; Boumans N; Panitti L; Fransen S; Vanormelingen J; Stassen JM; Leysen D; Defert O
    J Med Chem; 2015 May; 58(10):4309-24. PubMed ID: 25898023
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
    Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
    Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats.
    Zhang L; Li Q; Liu Z; Liu W; Zhao M
    Inflammation; 2018 Dec; 41(6):2171-2183. PubMed ID: 30088170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis of 3-hydroxy-6-oxo[1,2,4]triazin-1-yl alaninamides, a new class of cyclic dipeptidyl ureas.
    Sañudo M; Marcaccini S; Basurto S; Torroba T
    J Org Chem; 2006 Jun; 71(12):4578-84. PubMed ID: 16749791
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discovery of 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucoma.
    Sun Y; Li Y; Miao Z; Yang R; Zhang Y; Wu M; Lin G; Li L
    Bioorg Med Chem Lett; 2021 Aug; 45():128138. PubMed ID: 34044123
    [TBL] [Abstract][Full Text] [Related]  

  • 67. ROCK inhibitors 4: Structure-activity relationship studies of 7-azaindole-based rho kinase (ROCK) inhibitors.
    Bandarage UK; Court J; Gao H; Nanthakumar S; Come JH; Giroux S; Green J
    Bioorg Med Chem Lett; 2021 Feb; 33():127721. PubMed ID: 33259926
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of a Potent, Selective, and Brain-Penetrant Rho Kinase Inhibitor and its Activity in a Mouse Model of Huntington's Disease.
    Ladduwahetty T; Lee MR; Maillard MC; Cachope R; Todd D; Barnes M; Beaumont V; Chauhan A; Gallati C; Haughan AF; Kempf G; Luckhurst CA; Matthews K; McAllister G; Mitchell P; Patel H; Rose M; Saville-Stones E; Steinbacher S; Stott AJ; Thatcher E; Tierney J; Urbonas L; Munoz-Sanjuan I; Dominguez C
    J Med Chem; 2022 Jul; 65(14):9819-9845. PubMed ID: 35816678
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinct Roles For ROCK1 and ROCK2 in the Regulation of Oxldl-Mediated Endothelial Dysfunction.
    Huang L; Dai F; Tang L; Bao X; Liu Z; Huang C; Zhang T; Yao W
    Cell Physiol Biochem; 2018; 49(2):565-577. PubMed ID: 30165352
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease.
    Hartmann S; Ridley AJ; Lutz S
    Front Pharmacol; 2015; 6():276. PubMed ID: 26635606
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases.
    Thompson AM; Delaney AM; Hamby JM; Schroeder MC; Spoon TA; Crean SM; Showalter HD; Denny WA
    J Med Chem; 2005 Jul; 48(14):4628-53. PubMed ID: 16000000
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV protease.
    Tait BD; Hagen S; Domagala J; Ellsworth EL; Gajda C; Hamilton HW; Prasad JV; Ferguson D; Graham N; Hupe D; Nouhan C; Tummino PJ; Humblet C; Lunney EA; Pavlovsky A; Rubin J; Gracheck SJ; Baldwin ET; Bhat TN; Erickson JW; Gulnik SV; Liu B
    J Med Chem; 1997 Nov; 40(23):3781-92. PubMed ID: 9371244
    [TBL] [Abstract][Full Text] [Related]  

  • 73. RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vessels.
    Sun Z; Wu X; Li W; Peng H; Shen X; Ma L; Liu H; Li H
    BMC Cardiovasc Disord; 2016 Oct; 16(1):193. PubMed ID: 27724862
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structure-activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II.
    Feng Y; Cameron MD; Frackowiak B; Griffin E; Lin L; Ruiz C; Schröter T; LoGrasso P
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2355-60. PubMed ID: 17368019
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A key role for ROCK in TNF-α-mediated diabetic microvascular damage.
    Arita R; Nakao S; Kita T; Kawahara S; Asato R; Yoshida S; Enaida H; Hafezi-Moghadam A; Ishibashi T
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2373-83. PubMed ID: 23462755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of α-Methoxy Substitution on the Anti-HIV Activity of Dihydropyrimidin-4(3 H)-ones.
    Nawrozkij MB; Forgione M; Yablokov AS; Lucidi A; Tomaselli D; Patsilinakos A; Panella C; Hailu GS; Kirillov IA; Badia R; Riveira-Muñoz E; Crespan E; Armijos Rivera JI; Cirilli R; Ragno R; Esté JA; Maga G; Mai A; Rotili D
    J Med Chem; 2019 Jan; 62(2):604-621. PubMed ID: 30525601
    [TBL] [Abstract][Full Text] [Related]  

  • 77. ROCK inhibitors 2. Improving potency, selectivity and solubility through the application of rationally designed solubilizing groups.
    Gao H; Marhefka C; Jacobs MD; Cao J; Bandarage UK; Green J
    Bioorg Med Chem Lett; 2018 Aug; 28(15):2616-2621. PubMed ID: 29945794
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors.
    Dumas J; Hatoum-Mokdad H; Sibley R; Riedl B; Scott WJ; Monahan MK; Lowinger TB; Brennan C; Natero R; Turner T; Johnson JS; Schoenleber R; Bhargava A; Wilhelm SM; Housley TJ; Ranges GE; Shrikhande A
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2051-4. PubMed ID: 10999468
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Baicalein potently inhibits Rho kinase activity and suppresses actin stress fiber formation in angiotensin II-stimulated H9c2 cells.
    Oh KS; Oh BK; Park CH; Mun J; Won SH; Lee BH
    Biol Pharm Bull; 2012; 35(8):1281-6. PubMed ID: 22863926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Adamantyl-ureas with pyrazoles substituted by fluoroalkanes as soluble epoxide hydrolase inhibitors.
    Burmistrov VV; Morisseau C; Shkineva TK; Danilov DV; Gladkikh B; Butov GM; Fayzullin RR; Dutova TY; Hammock BD; Dalinger IL
    J Fluor Chem; 2023 Feb; 266():. PubMed ID: 37638129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.